Alzheimer’s Disease and Memory Loss Research Studies
To learn more about Alzheimer’s, memory loss and clinical trials being carried out in this area, visit our Alzheimer’s Disease Research page.
Learn MoreThe reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.
Participants must have gradual and progressive change in memory function reported by participants or informants for 6 months
Participants must have MMSE score of 20 to 28 (inclusive) at baseline
Participants must meet 18F flortaucipir PET scan (central read) criteria does not apply to participants in the safety cohort
Participants must have meet 18F florbetapir PET scan (central read) criteria
Participants must have a study partner who will provide written informed consent to participate
Participants must not have contraindication to MRI or PET scans
Participants must not receive current treatment with immunoglobulin G (IgG) therapy
To learn more about Alzheimer’s, memory loss and clinical trials being carried out in this area, visit our Alzheimer’s Disease Research page.
Learn MoreTo learn more about neurodegenerative diseases and clinical trials being carried out in the area, visit our Neurodegenerative Disease Research page.
A clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.